Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

The FDA is cracking down on those selling ‘dietary supplements’, having sent warning letters to companies who claim, without proof, that their...
Gilead’s treatment for the progressive fatty liver disease, NASH, has failed to meet its primary goal in a phase 3 trial, causing shares in the...
-GSK buys Merck KGaA's cancer immunotherapy for $4.2 billion -400 Pfizer employees set to strike over pensions -Takeda ordered to pay Bayer $155.19...
Eli Lilly has unveiled new Phase 3 data from two studies into the oral Janus kinase (JAK) inhibitor Olumiant (baricitinib). The company and its...
It’s a double victory for AstraZeneca as the company announced its F monoclonal antibody MEDI8897 has been granted accelerated review by both the...
There have been more than 200 deaths linked to misuse of the anti-anxiety drug Xanax in the UK since 2015.
Efforts to create an “abuse deterrent” OxyContin pill inadvertently led to an increase in the number of Hepatitis C infections, according to a...
Shares in Catalyst Pharmaceuticals plummeted Monday, after US Senator Bernie Sanders sent the firm a letter asking them to justify their decision to...
-Israeli biotech claims it has developed cure for cancer -Novartis warns of huge impact of no-deal Brexit -Stripper-turned-Insys sales rep gave lap...
With coverage of the biggest pharmaceutical merger of all time, new research which turns cancer cells to fat, as well as full-length features on how...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches